loadpatents
name:-0.018529891967773
name:-0.0093309879302979
name:-0.00047516822814941
CUSS; Francis M. Patent Filings

CUSS; Francis M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for CUSS; Francis M..The latest application filed is for "use of mometasone furoate for treating airway passage and lung disease".

Company Profile
0.10.15
  • CUSS; Francis M. - Basking Ridge NJ
  • Cuss; Francis M. - Bernardsville NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Mometasone Furoate For Treating Airway Passage And Lung Disease
App 20120134935 - SEQUEIRA; Joel A. ;   et al.
2012-05-31
Pulmonary Disease Treatment
App 20110200647 - Cuss; Francis M. ;   et al.
2011-08-18
Use Of Mometasone Furoate For Treating Airway Passage And Lung Disease
App 20100022493 - SEQUEIRA; JOEL A. ;   et al.
2010-01-28
Pulmonary Disease Treatment
App 20080107609 - Cuss; Francis M. ;   et al.
2008-05-08
High affinity ligands for nociceptin receptor ORL-1
Grant 7,094,784 - Tulshian , et al. August 22, 2
2006-08-22
Use of mometasone furoate for treating airway passage and lung disease
App 20050287080 - Sequeira, Joel A. ;   et al.
2005-12-29
Use of mometasone furoate for treating upper airway diseases
Grant 6,956,030 - Sequeira , et al. October 18, 2
2005-10-18
Use of mometasone furoate for treating airway passage and lung diseases
Grant 6,949,532 - Sequeira , et al. September 27, 2
2005-09-27
Pulmonary disease treatment
App 20050148563 - Cuss, Francis M. ;   et al.
2005-07-07
Use of mometasone furoate for treating upper airway diseases
App 20040223920 - Sequeira, Joel A. ;   et al.
2004-11-11
High affinity ligands for nociceptin receptor ORL-1
App 20040152707 - Tulshian, Deen ;   et al.
2004-08-05
Use of mometasone furoate for treating airway passage and lung diseases
App 20040152683 - Sequeira, Joel A. ;   et al.
2004-08-05
Use of mometasone furoate for treating upper airway diseases
Grant 6,723,713 - Sequeira , et al. April 20, 2
2004-04-20
High affinity ligands for nociceptin receptor ORL-1
App 20040067950 - Tulshian, Deen ;   et al.
2004-04-08
High affinity ligands for nociceptin receptor ORL-1
Grant 6,716,846 - Tulshian , et al. April 6, 2
2004-04-06
Use of mometasone furoate for treating airway passage and lung diseases
Grant 6,677,323 - Sequeira , et al. January 13, 2
2004-01-13
Use of mometasone furoate for treating airway passage and lung diseases
Grant 6,677,322 - Sequeira , et al. January 13, 2
2004-01-13
Use of mometasone furoate for treating airway passage and lung diseases
App 20030216365 - Sequeira, Joel A. ;   et al.
2003-11-20
High affinity ligands for nociceptin receptor ORL-1
App 20030073690 - Tulshian, Deen ;   et al.
2003-04-17
Use of mometasone furoate for treating airway passage and lung diseases
App 20020127187 - Sequeira, Joel A. ;   et al.
2002-09-12
Use of mometasone furoate for treating airway passage and lung diseases
App 20020103175 - Sequeira, Joel A. ;   et al.
2002-08-01
Use of mometasone furoate for treating airway passage and lung diseases
Grant 6,365,581 - Sequeira , et al. April 2, 2
2002-04-02
High affinity ligands for nociceptin receptor ORL-1
App 20010011092 - Tulshian, Deen ;   et al.
2001-08-02
Use of mometasone furoate for treating airway passage and lung diseases
Grant 6,057,307 - Sequeira , et al. May 2, 2
2000-05-02
Use of mometasone furoate for treating upper airway passage diseases
Grant 5,837,699 - Sequeira , et al. November 17, 1
1998-11-17
Company Registrations
SEC0001490216Cuss Francis M

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed